Back
HUTCHMED (China) Quote, Financials, Valuation and Earnings
Sponsored
HCM
Sponsored
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to See
Buy
75
HCM
HUTCHMED (China)
Last Price:
19.54
Seasonality Move:
2.07%
7 Day Trial
ALL ACCESS PASS
$
7
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!HUTCHMED (China) Price Quote
$19.54
+0.79 (+4.21%)
(Updated: May 2, 2024 at 6:55 PM ET)
HUTCHMED (China) Key Stats
Buy
75
HUTCHMED (China) (HCM)
is a Buy
Day range:
$18.31 - $18.96
52-week range:
$10.68 - $20.73
Dividend yield:
0%
P/E ratio:
31.25
P/S ratio:
3.89
P/B ratio:
4.38%
Volume:
28.1K
Avg. volume:
146.3K
1-year change:
24.09%
Market cap:
$3.2B
Revenue:
$838M
EPS:
$0.55
How Much Does HUTCHMED (China) Make?
-
How Much Are HUTCHMED (China)'s Sales Annually?
HCM Revenues are $838M -
How Much Profit Does HUTCHMED (China)'s Make A Year?
HCM net income is $100.8M
Is HUTCHMED (China) Growing As A Company?
-
What Is HUTCHMED (China)'s Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.52% -
What Is HUTCHMED (China)'s EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
HUTCHMED (China) Stock Price Performance
-
Did HUTCHMED (China) Stock Go Up Last Month?
HUTCHMED (China) share price went up by 11.81% last month -
Did HCM's Share Price Rise Over The Last Year?
HCM share price rose by 24.09% over the past 1 year
What Is HUTCHMED (China) 52-Week High & Low?
-
What Is HUTCHMED (China)’s 52-Week High Share Price?
HUTCHMED (China) has traded as high as $20.73 over the past 52 weeks -
What Is HUTCHMED (China)’s 52-Week Low Share Price?
HUTCHMED (China) has traded as low as $10.68 over the past 52 weeks
HUTCHMED (China) Price To Free Cash Flow
-
Is HUTCHMED (China) Stock Overvalued?
HUTCHMED (China) is trading at a price to free cash flow ratio of 17.46 -
Is HUTCHMED (China) Stock Undervalued?
HUTCHMED (China) EV to Free Cash Flow ratio is 12.90 -
What Is HUTCHMED (China)’s Price Earnings Growth Ratio?
HCM PEG ratio is 0.00 -
Is HUTCHMED (China) Trading At A Premium To Earnings?
HUTCHMED (China) EV to EBIT ratio is 40.75
Is It Risky To Buy HUTCHMED (China)?
-
How Much Debt Does HUTCHMED (China) Have?
Total long term debt quarterly is $79.3M -
How Much Cash Does HUTCHMED (China) Have?
Cash and short term investments quarterly total is $886.3M -
What Is HUTCHMED (China)’s Book Value Per Share?
Book value per share is 4.28
Is HUTCHMED (China) Cash Flow Positive?
-
What Is HCM Cash Flow From Operations?
Cash flow from operations (TTM) is $219.3M -
What Is HUTCHMED (China)’s Cash Flow From Financing?
Cash flow from financing (TTM) is $48.7M -
What Is HUTCHMED (China)’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$291.1M
HUTCHMED (China) Return On Invested Capital
-
Is Management Doing A Good Job?
HCM return on invested capital is 13.04% -
What Is HUTCHMED (China) Return On Assets?
ROA measures how assets are converting to revenues and is 8.38% -
What Is HCM Return On Equity?
ROE is a measure of profitability and is 13.87%
HUTCHMED (China) Earnings Date & Stock Price
-
What Is HUTCHMED (China)'s Stock Price Today?
A single share of HCM can be purchased today for 18.75 -
What Is HUTCHMED (China)’s Stock Symbol?
HUTCHMED (China) trades on the nasdaq under the ticker symbol: HCM -
When Is HUTCHMED (China)’s Next Earnings Date?
The next quarterly earnings date for HUTCHMED (China) is scheduled on July 31, 2024 -
When Is HCM's next ex-dividend date?
HUTCHMED (China)'s next ex-dividend date is June 18, 2020 -
How To Buy HUTCHMED (China) Stock?
You can buy HUTCHMED (China) shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
HUTCHMED (China) Competitors
-
Who Are HUTCHMED (China)'s Competitors?
Below is a list of companies who compete with HUTCHMED (China) or are related in some way:
HUTCHMED (China) Dividend Yield
Data Unavailable
HUTCHMED (China) Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 51.52% | 0% |
Analyst Recommendations
Buy Recommendations: | 7 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 29.06 |
Upside from Last Price: | 54.98% |